INTERNATIONAL PATENT: SHANGHAI JEYOU PHARMACEUTICAL CO., LTD, 上海济煜医药科技有限公司 FILES APPLICATION FOR "USE OF ANTI-ADRENOMEDULLIN ANTIBODY IN PREVENTION OR TREATMENT OF CEREBRAL STROKE"

GENEVA, July 28 -- SHANGHAI JEYOU PHARMACEUTICAL CO., LTD (1st Floor, Building No. 2, Lane 535, Huanqiao RoadPudong New Area, Shanghai 201315), 上海济煜医药科技有限公司 (中国上海市浦东新区环桥路535弄2号1层) filed a patent application (PCT/CN2025/072203) for "USE OF ANTI-ADRENOMEDULLIN ANTIBODY IN PREVENTION OR TREATMENT OF CEREBRAL STROKE" on Jan 14, 2025. With publication no. WO/2025/152915, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is...